Wins "Sustainability Leadership" and "Best in Class" Awards

Samsung Biologics announced on March 30 that it has been awarded in the "Sustainability Leadership" category at the prestigious global "CDMO Leadership Awards." With this achievement, the company has become the first Korean company to win the award for 13 consecutive years.


The CDMO Leadership Awards is a global awards ceremony jointly organized by Outsourced Pharma, a pharmaceutical and biotech industry research institute, and Life Science Connect, a life sciences publication. This year, Samsung Biologics was honored with the Jury Award in the Sustainability Leadership category. The award is presented based on a comprehensive evaluation of leadership, innovation, and influence across the CDMO industry, conducted by an independent panel of global industry experts who consider survey results and industry feedback. Samsung Biologics was recognized for its efforts to implement sustainable production processes and reduce environmental impact.

Officials from Samsung Biologics are taking a commemorative photo after receiving the CDMO Leadership Awards. From left to right: Kevin Sharp, Vice President of Sales and Operations; James Choi, Vice President of Sales Support; Jin Yong Kim, CMO Sales Director of Samsung Biologics America. Samsung Biologics

Officials from Samsung Biologics are taking a commemorative photo after receiving the CDMO Leadership Awards. From left to right: Kevin Sharp, Vice President of Sales and Operations; James Choi, Vice President of Sales Support; Jin Yong Kim, CMO Sales Director of Samsung Biologics America. Samsung Biologics

View original image

In addition, Samsung Biologics received the "Best in Class" award in the "Cultural Fit" category among large CDMO companies in the biopharmaceutical sector. The company was praised for demonstrating its value as the optimal partner that clients want to work with, thanks to its close customer engagement and smooth communication.



John Rim, CEO of Samsung Biologics, stated, "This award is the result of the unwavering trust from our clients and the dedicated efforts of all our employees to practice company-wide sustainable management. Moving forward, we will continue to lead sustainable innovation by supplying high-quality pharmaceuticals in a timely manner through close collaboration with our global partners."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing